期刊文献+

诺合灵30R联合吡格列酮治疗高龄2型糖尿病疗效观察

下载PDF
导出
摘要 2型糖尿病(T2DM)是一种随年龄递增而递增的慢性代谢性疾病,伴有胰岛素抵抗的发生和胰岛β细胞功能衰竭,而胰岛素抵抗占有更重要的地位。因而降低胰岛素抵抗在糖尿病治疗过程中十分重要。
作者 宋英 傅铦
出处 《华北煤炭医学院学报》 2010年第5期660-661,共2页 Journal of North China Coal Medical College
  • 相关文献

参考文献7

  • 1纪立农.胰岛素增敏剂及其应用前景[J].当代医学,2001,7(2):25-30. 被引量:9
  • 2《糖尿病防治指南》编写组.中国糖尿病防治指南[M].北京:北京大学医学出版社,2004:72-152.
  • 3王佑民,杨明功,刘树琴.长期高血糖对继发磺脲类药物失效患者胰岛β细胞功能的影响[J].中国糖尿病杂志,2004,12(1):2-4. 被引量:21
  • 4陈燕燕,邢小燕,冯凭,纪立农,刘俊江,王瑶,孙瑞华,杨文英,李光伟.罗格列酮对2型糖尿病患者血糖及血压的影响[J].中国糖尿病杂志,2007,15(6):348-351. 被引量:13
  • 5Hayakawa T, Shiraki T, Morimoto T, et al. Pioglitazone improves insulin signs ling defects in skeletal from Wistar fatty(fa/fa) rats[ J]. Biechem Biophys Bes Commun,1996,223:439.
  • 6Roseublatt S, Miskin B, Glazer NB,et al. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus[ J ]. Comma Artery Dis,2001 , 12:413.
  • 7Shimaya A, Kurosaki E, Nakano R, et al. The novel hypoglycemic agent YM440 normalizes hyperglyee mia without changing bodyfat weight in diabetic db/db mice[ J]. Metabolism,2000,49(3 ) :411.

二级参考文献32

  • 1李光伟,王金平,李春梅,陈燕燕,杨文英,邢小燕,刘克莉,唐玉龙,黎辉.胰岛素增敏剂罗格列酮抗高血压作用探讨[J].中华内科杂志,2004,43(12):907-910. 被引量:55
  • 2李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2125
  • 3Cederholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract, 1990,10:167-175.
  • 4Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care, 2000,23 : 295-301.
  • 5Prigeon RL, Kahn SE, Porte D. Effect of troglitazone on B cell function, insulin sensitivity, and glycemic control in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab, 1998,83:819-823.
  • 6李光伟.胰岛素抵抗和胰岛β细胞功能评估[A].见:胡仁明主编.内分泌代谢病临床新技术,第1版[C].北京:人民军医出版社,2002.423-433.
  • 7Robertson RP, Olson LK, Zhartg HJ. Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes, 1994, 43 : 1085-1089.
  • 8Pfeifer MA, Halter JB, Porte D Jr. Insulin secretion in diabetes mellitus. Am J Med, 1981,70:579-588.
  • 9Nolan JJ,Jones N P,Patw archum R,et al.Rosiglitazone taken once daily provides effective glycaemic control in patients with type 2 diabetes mellitus.Diabet Med,2000,17:287-294.
  • 10Patel J,Miller E,Patwardhan R.Rosiglitazone (BRL49653) monotherapy has significant glucose lowering effect in type 2 diabetic patients.Diabetes,1998,47(suppl 1):A17.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部